Stromecki, M., Tatari, N., Morrison, L. C., Kaur, R., Zagozewski, J., Palidwor, G., . . . Werbowetski‐Ogilvie, T. E. (2018). Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma. Mol Oncol.
Παραπομπή Chicago StyleStromecki, Margaret, et al. "Characterization of a Novel OTX2‐driven Stem Cell Program in Group 3 and Group 4 Medulloblastoma." Mol Oncol 2018.
Παραπομπή MLAStromecki, Margaret, et al. "Characterization of a Novel OTX2‐driven Stem Cell Program in Group 3 and Group 4 Medulloblastoma." Mol Oncol 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.